Should access to GLP-1 weight-loss drugs be publicly reimbursed?
14 votes|10 arguments|0 source
36%5
·
Once enacted, this kind of policy is politically very hard to reverse — that asymmetry alone calls for caution. @@no_4
WHO priority pathogens list and pandemic preparedness
Report·who.int
Updated assessment of viral families with pandemic potential, including hantaviruses, coronaviruses and arenaviruses.
Added by @tomas
Publicly funded trials of repurposed drugs: the case for state action
Article·thelancet.com
Why off-patent molecules with oncology signals stall, and what public trial infrastructure could change.
Added by @priya